Table of Contents Author Guidelines Submit a Manuscript
Enzyme Research
Volume 2016, Article ID 9040616, 7 pages
http://dx.doi.org/10.1155/2016/9040616
Research Article

Molecular Analysis of CYP21A2 Gene Mutations among Iraqi Patients with Congenital Adrenal Hyperplasia

1Genetic Counseling Clinic and Genetics Laboratory, The Teaching Laboratories, Medical City, Baghdad, Iraq
2Department of Pathology, College of Medicine, Baghdad University, Baghdad, Iraq
3Department of Pediatrics, College of Medicine, Baghdad University and Pediatric Endocrine Consultation Clinic, Children Welfare Hospital, Baghdad, Iraq
4ViennaLab Diagnostics GmbH, Gaudenzdorfer Guertel 43-45, 1120 Vienna, Austria
5National Center of Hematology, Al-Mustansiriya University, Baghdad, Iraq

Received 12 June 2016; Accepted 31 August 2016

Academic Editor: Hartmut Kuhn

Copyright © 2016 Ruqayah G. Y. Al-Obaidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Merke, “Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 653–660, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Lin-Su, M. C. Macapagal, R. C. Wilson, and M. I. New, “Genetic disorder of the adrenal gland,” in Principles and Practice of Medical Genetics, D. L. Rimon, J. M. Connor, R. E. Pyeritz, and B. R. Korf, Eds., vol. 2, pp. 2023–2054, Churchill Livingstone, Philadelphia, Pa, USA, 5th edition, 2007. View at Google Scholar
  3. P. White and T. A. S. S. Bachega, “Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood,” Seminars in Reproductive Medicine, vol. 30, no. 5, pp. 400–409, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. F. Witchel and R. Azziz, “Congenital adrenal hyperplasia,” Journal of Pediatric and Adolescent Gynecology, vol. 24, no. 3, pp. 116–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. C. Wilson, S. Nimkarn, M. Dumic et al., “Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency,” Molecular Genetics and Metabolism, vol. 90, no. 4, pp. 414–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Pang and A. Clark, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder,” Screening, vol. 2, article 105, 1993. View at Google Scholar
  7. S. Mohamed, S. El-Kholy, N. Al-Juryyan, A. M. Al-Nemri, and K. K. Abu-Amero, “A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia. Molecular genetics report from Saudi Arabia,” Saudi Medical Journal, vol. 36, no. 1, pp. 113–116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Al Hosani, M. Salah, H. M. Osman et al., “Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011,” Eastern Mediterranean Health Journal, vol. 20, no. 1, pp. 17–23, 2014. View at Google Scholar · View at Scopus
  9. J. Sack, H. Front, I. Kaiserman, and M. Schreiber, “21-Hydroxylase deficiency: screening and incidence in Israel,” Hormone Research, vol. 48, no. 3, pp. 115–119, 1997. View at Google Scholar
  10. F. Baş, H. Kayserili, F. Darendeliler et al., “CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children,” Journal of Turkish Pediatric Endocrinology and Diabetes Society, vol. 1, no. 3, pp. 116–128, 2009. View at Publisher · View at Google Scholar
  11. H. Daggag, D. Hiyesat, N. Khawaja et al., “Prevalence of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in Jordanian sample pool,” in Proceedings of the Endocrine Society's 93rd Annual Meeting & Expo, National Center for Diabetes Endocrinology and Genetics, Boston, Mass, USA, June 2011.
  12. B. Rabbani, N. Mahdieh, M. T. Ashtiani, M. T. Akbari, and A. Rabbani, “Molecular diagnosis of congenital adrenal hyperplasia in Iran: focusing on CYP21A2 gene,” Iranian Journal of Pediartrics, vol. 21, no. 2, pp. 139–150, 2011. View at Google Scholar
  13. A. Ramazani, K. Kahrizi, M. Razaghiazar, N. Mahdieh, and P. Koppens, “The frequency of eight common point mutations in CYP21 gene in Iranian patients with congenital adrenal hyperplasia,” Iranian Biomedical Journal, vol. 12, no. 1, pp. 49–53, 2008. View at Google Scholar · View at Scopus
  14. M. Kharrat, V. Tardy, R. M'Rad et al., “Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 368–374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Németh, S. Riedl, G. Kriegshäuser et al., “Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone,” Clinica Chimica Acta, vol. 414, pp. 211–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. A. S. Al-Allawi, B. M. S. Al-Mousawi, A. I. A. Badi, and S. D. Jalal, “The spectrum of β-Thalassemia mutations in Baghdad, Central Iraq,” Hemoglobin, vol. 37, no. 5, pp. 444–453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. N. A. S. Al-Allawi, J. M. S. Jubrael, and M. Hughson, “Molecular characterization of β-thalassemia in the Dohuk region of Iraq,” Hemoglobin, vol. 30, no. 4, pp. 479–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. S. Al-Musawi, N. Al-Allawi, B. A. Abdul-Majeed, A. A. Eissa, J. M. S. Jubrael, and H. Hamamy, “Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city—Iraq,” BMC Blood Disorders, vol. 12, article 4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. N. A. S. Al-Allawi, S. D. Jalal, A. M. Mohammad, S. Q. Omer, and R. S. D. Markous, “β-Thalassemia intermedia in Northern Iraq: a single center experience,” BioMed Research International, vol. 2014, Article ID 262853, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. P. C. White and P. W. Speiser, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Endocrine Reviews, vol. 21, no. 3, pp. 245–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Ben Charfeddine, F. G. Riepe, E. Clauser et al., “Steroid 21-hydroxylase gene mutational spectrum in 50 Tunisian patients: characterization of three novel polymorphisms,” Gene, vol. 507, no. 1, pp. 20–26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Dracopoulou-Vabouli, M. Maniati-Christidi, and C. Dacou-Voutetakis, “The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 6, pp. 2845–2848, 2001. View at Google Scholar
  23. A. G. Sido, M. M. Weber, P. G. Sido, S. Clausmeyer, U. Heinrich, and E. Schulze, “21-Hydroxylase and 11β-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 10, pp. 5769–5773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Carrera, L. Bordone, T. Azzani et al., “Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency,” Human Genetics, vol. 98, no. 6, pp. 662–665, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Zhang, Z.-L. Lu, Y. Wang, and H. Tao, “Molecular characterization of mutations and phenotype/genotype correlation in Chinese patients with 21-hydroxylase deficiency,” Acta Genetica Sinica, vol. 31, no. 9, pp. 950–955, 2004. View at Google Scholar · View at Scopus
  26. V. Dolžan, J. Sólyom, G. Fekete et al., “Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia,” European Journal of Endocrinology, vol. 153, no. 1, pp. 99–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Sadeghi, N. Yurur-Kutlay, M. Berberoglu et al., “Identification of frequency and distribution of the nine most frequent mutations among patients with 21-hydroxylase deficiency in Turkey,” Journal of Pediatric Endocrinology and Metabolism, vol. 21, no. 8, pp. 781–787, 2008. View at Google Scholar · View at Scopus
  28. P. A. Levy and R. W. Marion, “Human genetics and dysmorphology,” in Nelson Essentials of Pediatrics, K. J. Marcdante and R. M. Kliegman, Eds., p. 150, Elsevier, Philadelphia, Pa, USA, 7th edition, 2015. View at Google Scholar
  29. R. C. Wilson and M. I. New, “Congenital adrenal hyperplasia,” in Principles of Molecular Medicine, Humana Press, Totowa, NJ, USA, 1998. View at Google Scholar
  30. L. I. Alshabab, A. Alebrahem, A. Kaddoura, and S. Al-Fahoum, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a five-year retrospective study in the Children's Hospital of Damascus, Syria,” Qatar Medical Journal, vol. 2015, no. 1, article 11, 2015. View at Publisher · View at Google Scholar
  31. H. A. Hamamy and Z. S. AL-Hakkak, “Consanguinity and reproductive health in Iraq,” Human Heredity, vol. 39, no. 5, pp. 271–275, 1989. View at Publisher · View at Google Scholar · View at Scopus
  32. K.-K. Chin and S.-F. Chang, “The −104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction,” Nucleic Acids Research, vol. 26, no. 8, pp. 1959–1964, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. P. W. Speiser, L. Agdere, H. Ueshiba, P. C. White, and M. I. New, “Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase,” The New England Journal of Medicine, vol. 324, no. 3, pp. 145–149, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Rabbani, M. T. Akbari, N. Mahdieh et al., “Homozygous complete deletion of CYP21A2 causes a simple virilizing phenotype in an Azeri child,” Asian Biomedicine, vol. 5, no. 6, pp. 889–892, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Marino, P. Ramirez, J. Galeano et al., “Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia,” Clinical Endocrinology, vol. 75, no. 4, pp. 427–435, 2011. View at Publisher · View at Google Scholar · View at Scopus